Overall rank by patents
#569
Across all tracked assignees
USPTO PatentsView assignee record - 790 granted patents across 133 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60R (VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR).
The verdict
Gentex holds 790 US patents across 133 technology areas, rank #569 of 50,000 tracked assignees.
Gentex Corporation has been granted 790 US utility patents between 2015 and 2025, placing Gentex Corporation at rank #569 across all assignees tracked by PlainPatent. This portfolio spans 133 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.2 claims per patent with primary concentration in B60R (VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR). As a US Corporation, Gentex Corporation is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Gentex sits between Resmed Pty Ltd (800 patents, rank #565) and Stmicroelectronics International N.v. (787 patents, rank #573) - the closest US assignees by grant volume. The composite Innovation Score of 60.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 382 grants, compared with 408 in the 2015–2019 window, a -6% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Gentex Corporation's 14.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gentex Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ResMed Pty Ltd
800 patents
Wipro Limited
794 patents
ALCON INC.
793 patents
Bally Gaming, Inc.
792 patents
GENTEX CORPORATION
790 patents
YETI Coolers, LLC
789 patents
ABBOTT DIABETES CARE INC.
788 patents
Yokogawa Electric Corporation
788 patents
STMicroelectronics International N.V.
787 patents
What this shows Gentex holds 790 patents at rank #569, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #569 in granted patent volume.
Other assignees with the most granted patents in Gentex's primary technology class.
Gentex's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
60 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 56 | 7.1% |
| 2016 | 65 | 8.2% |
| 2017 | 84 | 10.6% |
| 2018 | 87 | 11.0% |
| 2019 | 116 | 14.7% |
| 2020 | 103 | 13.0% |
| 2021 | 81 | 10.3% |
| 2022 | 65 | 8.2% |
| 2023 | 47 | 5.9% |
| 2024 | 51 | 6.5% |
| 2025 | 35 | 4.4% |
Top 15 of 133 technology areas
Overall rank by patents
#569
Across all tracked assignees
60.2 out of 100
How to use this portfolio
Gentex's 790 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.